Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-17

Clinical Trial Update: 64Cu-GRIP B in Patients With Advanced Malignancies [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for a Phase 1/Phase 2 study of 64Cu-GRIP B in advanced malignancies, including prostate and renal cancers, which is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 64Cu-GRIP B

Snippet

Sponsor: Rahul Aggarwal | Conditions: Prostate Cancer, Renal Cancer | Phase 1, Phase 2 | Status: RECRUITING